Fredun Pharmaceuticals

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue79.8162.0581.9887.00118.03
Expenses71.7957.9676.2281.25112.19
EBITDA12.267.619.6110.5211.17
EBIT11.566.698.679.5310.21
Profit Before Tax8.014.085.775.765.84
Net Profit3.892.403.944.225.06
Financial Ratios
Operating Profit Margin15.38%12.43%11.79%12.14%9.53%
Net Profit Margin4.88%3.92%4.84%4.87%4.32%
Earning Per Share (Diluted)8.595.248.408.9910.77
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.9.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ